Tumoral Melanosis and Separate Granulomatous Inflammation due to Talimogene Laherparepvec

Tumoral Melanosis and Separate Granulomatous Inflammation due to Talimogene Laherparepvec

Bibliographic Details
Main Authors:	Lee, B.A (Author), Linden, K.G (Author), Shwe, S. (Author), Yamamoto, M. (Author)
Format:	Article
Language:	English
Published:	NLM (Medline) 2022
Subjects:	biological product Biological Products Herpesvirus 1, Human human Human alphaherpesvirus 1 Humans inflammation Inflammation melanoma Melanoma melanosis Melanosis oncolytic virotherapy Oncolytic Virotherapy Skin Neoplasms skin tumor talimogene laherparepvec
Online Access:	View Fulltext in Publisher

Similar Items

Spotlight on talimogene laherparepvec for the treatment of melanoma lesions in the skin and lymph nodes
by: Orloff M
Published: (2016-10-01)

Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma
by: Pier Francesco Ferrucci, et al.
Published: (2021-03-01)

Talimogene laherparepvec for regionally advanced Merkel cell carcinoma: A report of 2 cases
by: Jonathan T. Blackmon, et al.
Published: (2017-05-01)

Inflammatory melanoma in transit metastases with complete response to talimogene laherparepvec
by: Jonathan T. Blackmon, et al.
Published: (2017-07-01)

Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma
by: Robert H. I. Andtbacka, et al.
Published: (2019-06-01)

Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition
by: Zoë Blake, et al.
Published: (2018-04-01)

Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial
by: Harrington KJ, et al.
Published: (2016-11-01)

Adrenal Gland and Gastric Malignant Melanoma without Evidence of Skin Lesion Treated with the Oncolytic Virus Rigvir
by: Guna Proboka, et al.
Published: (2020-04-01)

Talimogene Laherparepvec in Advanced Mucosal Melanoma of the Urethra Upon Primary Resistance on Immune Checkpoint Inhibition: A Case Report
by: Anne Fröhlich, et al.
Published: (2020-05-01)

Editorial announcing PubMed indexing of Oncolytic Virotherapy
by: Farassati F
Published: (2017-02-01)

Kaposi’s varicelliform eruption in a patient with metastatic melanoma and primary cutaneous anaplastic large cell lymphoma treated with talimogene laherparepvec and nivolumab
by: David M. Miller, et al.
Published: (2018-11-01)

Combination gene therapy for colorectal cancer
by: Chen, Ming-Jen
Published: (2003)

Myxoma Virus-Loaded Mesenchymal Stem Cells in Experimental Oncolytic Therapy of Murine Pulmonary Melanoma
by: Joanna Jazowiecka-Rakus, et al.
Published: (2020-09-01)

Diffuse melanosis cutis secondary to metastatic malignant melanoma: case report
by: Cheymae Saadani Hassani, et al.
Published: (2019-01-01)

A practical guide to the handling and administration of talimogene laherparepvec in Europe
by: Harrington KJ, et al.
Published: (2017-08-01)

Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy
by: Mohsen Keshavarz, et al.
Published: (2019-06-01)

Oncolytic viruses for the treatment of malignant glioma
by: Hong⁃yu LIU, et al.
Published: (2020-02-01)

Oncolytic Adenoviruses in Cancer Treatment
by: Ramon Alemany
Published: (2014-02-01)

Measles to the Rescue: A Review of Oncolytic Measles Virus
by: Sarah Aref, et al.
Published: (2016-10-01)

To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses
by: Kevin A. Cassady, et al.
Published: (2016-02-01)

From Benchtop to Bedside: A Review of Oncolytic Virotherapy
by: Audrey H. Choi, et al.
Published: (2016-08-01)

Enhancing Oncolytic Adenovirus Vector Efficacy through Co-expression of the p14 Fusion-associated Small Transmembrane Protein and Adenovirus Death Protein
by: Clarkin, Ryan Gregory
Published: (2018)

Interventional oncology: A snapshot of expanding practice
by: Azzam Khankan
Published: (2017-01-01)

Interventional oncology: A snapshot of expanding practice
by: Azzam Khankan
Published: (2017-01-01)

Complete remission from intralesional talimogene laherparepvec for regionally advanced Merkel cell carcinoma in an immunocompromised solid organ transplant patient
by: Kelsey E. Hirotsu, MD, et al.
Published: (2021-07-01)

Prostatic Melanosis: A Case Report
by: Tufan Cicek, et al.
Published: (2014-06-01)

Harnessing the Potential of Combination Immunotherapy and Oncolytic Virotherapy for Solid Tumors
by: Boland, G.M, et al.
Published: (2022)

Oncolytic Virotherapy and Microenvironment in Multiple Myeloma
by: Valentina Marchica, et al.
Published: (2021-02-01)

Engineered oncolytic virus for the treatment of cholesteatoma: A pilot in vivo study
by: Ravi N. Samy, et al.
Published: (2019-10-01)

Decreasing the Susceptibility of Malignant Cells to Infection Does Not Impact the Overall Efficacy of Myxoma Virus-Based Oncolytic Virotherapy
by: Erica B. Flores, et al.
Published: (2020-12-01)

Virus-Based Immunotherapy of Glioblastoma
by: Miika Martikainen, et al.
Published: (2019-02-01)

Oncolytic Virotherapy in Glioma Tumors
by: Sergio Rius-Rocabert, et al.
Published: (2020-10-01)

Treating cancerous cells with viruses: insights from a minimal model for oncolytic virotherapy
by: Adrianne L. Jenner, et al.
Published: (2018-06-01)

The Continued Promise and Many Disappointments of Oncolytic Virotherapy in Gastrointestinal Malignancies
by: Daniel H. Ahn, et al.
Published: (2017-03-01)

Potential of oncolytic viruses in the treatment of multiple myeloma
by: Bartee E
Published: (2018-02-01)

Advances in the design and development of oncolytic measles viruses
by: Hutzen B, et al.
Published: (2015-08-01)

Oncolytic Virotherapy with Myxoma Virus
by: Masmudur M. Rahman, et al.
Published: (2020-01-01)

Combining HDAC inhibitors with oncolytic virotherapy for cancer therapy
by: Nakashima H, et al.
Published: (2015-11-01)

The Oncolytic Virotherapy Era in Cancer Management: Prospects of Applying H-1 Parvovirus to Treat Blood and Solid Cancers
by: Assia L. Angelova, et al.
Published: (2017-05-01)

A metastatic malign melanoma case with diffuse cutaneous melanosis
by: Zeynep Oruç, et al.
Published: (2016-08-01)